Abstract
Vancomycin-resistant enterococci have been isolated with increasing frequency since 1988. Thus far, most of these resistant enterococci have belonged to theEnterococcus faecium species, and epidemiological studies have shown a wide diversity among inter-hospital and intrahospital isolates. This report presents an epidemiologic investigation of 25 vancomycin-resistantEnterococcus strains — 24Enterococcus faecium and oneEnterococcus gallinarum — isolated from the stools or blood of adult patients receiving intravenous vancomycin prophylaxis during neutropenia and hospitalized in a single hematologic unit. Macrorestriction patterns of total DNA and of ribosomal DNA regions were used to analyze the strains. Strains produced different total DNA restriction fragment length polymorphism patterns after Smal digestion. Ribotyping was less discriminative than pulsed-field gel electrophoresis. The results confirmed the genetic unrelatedness of the strains. Prolonged vancomycin administration, commonly used in hematologic units, could be involved in the selection of endogenous resistant enterococcal strains.
Similar content being viewed by others
References
Kaplan AH, Gilligan PH, Facklam RR: Recovery of resistant enterococci during vancomycin prophylaxis. Journal of Clinical Microbiology 1988, 26: 1216–1218.
Dutka-Malen S, Blaimont B, Wauters G, Courvalin P: Emergence of high-level resistance to glycopeptides inEnterococcus gallinarum andEnterococcus casseliflavus. Antimicrobial Agents and Chemotherapy 1994, 38: 1675–1677.
Dutka-Malen S, Leclercq R, Coutant V, Duval J, Courvalin P: Phenotypic and genotypic heterogeneity of glycopeptide resistance determinants in gram-positive bacteria. Antimicrobial Agents and Chemotherapy 1990, 34: 1875–1879.
Arthur M, Molinas C, Depardieu F, Courvalin P: Characterization ofTn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors inEnterococcus faecium BM4147. Journal of Bacteriology 1993, 175: 117–127.
Gold HS, Unal S, Cercenado E, Thauvin-Eliopoulos C, Eliopoulos GM, Wennersten CB, Moellering RC: A gene conferring resistance to vancomycin but not teicoplanin in isolates ofEnterococcus faecalis andEnterococcus faecium demonstrates homology withvanB, vanA andvanC genes of enterococci. Antimicrobial Agents and Chemotherapy 1993, 37: 1604–1609.
Leclercq R, Dutka-Malen S, Duval J, Courvalin P: Vancomycin resistance genevanC is specific toEnterococcus gallinarum. Antimicrobial Agents and Chemotherapy 1992, 36: 2005–2008.
Boom R, Sol CJA, Salimans MMM, Jansen CL, Wertheim-Van Dillen PME, Van Der Noorda J: Rapid and simple method for purification of nucleic acids. Journal of Clinical Microbiology 1990, 28: 495–503.
Clark NC, Cooksey RC, Hill BC, Swenson JM, Tenover FC: Characterization of glycopeptide-resistant enterococci from US hospitals. Antimicrobial Agents and Chemotherapy 1993, 37: 2311–2317.
Griffais R, André PM, Thibon M: K-tuple frequency in the human genome and polymerase chain reaction. Nucleic Acids Research 1991, 19: 3887–3891.
Bétrémieux P, Donnio PY, Pladys P: Use of ribotyping to investigate trachéal colonisation byStaphylococcus epidermidis as a source of bacteremia in ventilated newborns. European Journal of Clinical Microbiology & Infectious Diseases 1995, 14: 342–346.
Wilson KH, Blitchington RB, Greene RC: Amplification of bacterial 16S ribosomal DNA with polymerase chain reaction. Journal of Clinical Microbiology 1990, 28:1942–1946.
Griffais R, André PM, Thibon M: Synthesis of digoxigenin-labelled DNA probe to polymerase chain reaction: application to Epstein-Barr virus andChlamydia trachomatis. Research in Virology 1990, 141: 331–335.
Branger B, Bouziges N, Houles R: Epidémie d'infection à streptocoques du groupe G dans une unité d'hémodialyse. Néphrologie 1991, 12: 227–232.
Lamy T, Michelet C, Dauriac C, Donnio PY, Le Prisé PY: Benefit of prophylaxis by intravenous systemic vancomycin in granulocytopenic patients: a prospective, randomized trial among 59 patients. Acta Haematologia 1993, 90: 109–113.
Attal M, Schlaifer D, Rubie H, Huguet F, Charlet JP, Bloom E, Lemozy J, Massip P, Pris J, Laurent G: Prevention of gram-positive infections after bone marrow transplantation by systemic vancomycin: a prospective, randomized trial. Journal of Clinical Oncology 1991, 5: 865–870.
Leclerq R, Derlot E, Duval J, Courvalin P: Plasmid-mediated resistance to vancomycin and teicoplanin inEnterococcus faecium. New England Journal of Medicine 1988, 319: 157–161.
Uttley AHC, George RC, Naidoo J, Woodford N, Johnson AP, Collins CH, Morrison D, Gilfillan AF, Fitch LE, Heptonstall J: High-level vancomycin-resistant enterococci causing hospital infections. Epidemiology and Infection 1989, 103: 173–181.
Sader HS, Pfaller MA, Tenover FC, Hollis RJ, Jones RN: Evaluation and characterization of multiresistantEnterococcus faecium from 12 US medical centers. Journal of Clinical Microbiology 1994, 32: 2840–2842.
Woodford N, Morrisson D, Johnson AP, Briant V, George RC, Cookson B: Application of DNA probes for rRNA andvanA genes to investigation of a nosocomial cluster of vancomycin-resistant enterococci. Journal of Clinical Microbiology 1993, 31: 653–658.
Bingen EH, Denamur E, Lambert-Zechovsky N, Elion J: Evidence for the genetic unrelatedness of nosocomial vancomycin-resistant strains in a pediatric hospital. Anti-microbial Agents and Chemotherapy 1991, 29: 1888–1892.
Leclerq R: Epidémiologie de la résistance aux glycopeptides. In: Couland JP, Pocidalo JJ, Régnier B, Vachon F, Vildé JL (ed): Infection nosocomiale et résistance aux antibiotiques: évolution et tendances. Journées de l'Hospital Claude-Bernard. Arnette, Paris, 1993, p. 79–87.
Auge B, Donnio PY, Le Déaut P, Avril JL: Influence de la vancomycine par voie veineuse sur les flores aérobies salivaires et fécales. Pathologie Biologie 1987, 35: 673–675.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Plessis, P., Lamy, T., Donnio, P.Y. et al. Epidemiologic analysis of glycopeptide-resistantEnterococcus strains in neutropenic patients receiving prolonged vancomycin administration. Eur. J. Clin. Microbiol. Infect. Dis. 14, 959–963 (1995). https://doi.org/10.1007/BF01691377
Issue Date:
DOI: https://doi.org/10.1007/BF01691377